Home / PAYD : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does PAYD make money? Does PAYD have pricing power? What's the Earnings Whisper? Will PAYD profit more as the business scales? What is PAYD's management track record? Is PAYD's current price justified?

PAID, Inc.

$2.46 -$0.49 (-16.61%)

OTC · 14 Sep 2026 20:00 UTC

Previous Close

$2.46

Day Range

$2.4$2.46

Year Range

$1.47$3.3

Market Cap

20.85M

AVG Volume

494

Trailing/Forward PE

159.74/-

PEG ratio

0.35

Dividend Yield

Next Earnings Date

Primary Exchange

Other OTC

Revenue (USD)

PAYD Revenue (USD) by quarter
Period	Revenue (USD)
26 Q2	5.87M
26 Q1	5.33M
25 Q4	5.39M
25 Q3	5.51M
25 Q2	5.43M
25 Q1	4.38M
24 Q4	5.38M
24 Q3	4.45M
24 Q2	4.6M
24 Q1	4.16M

Net Income (USD)

PAYD Net Income (USD) by quarter
Period	Net Income (USD)
26 Q2	-7.4K
26 Q1	-41.53K
25 Q4	145.72K
25 Q3	32.16K
25 Q2	-397.35K
25 Q1	-148.77K
24 Q4	-172.74K
24 Q3	-133.68K
24 Q2	770.45K
24 Q1	299.56K

Operating Income (USD)

PAYD Operating Income (USD) by quarter
Period	Operating Income (USD)
26 Q2	-23.17K
26 Q1	-117.72K
25 Q4	-113.58K
25 Q3	25.25K
25 Q2	-407.31K
25 Q1	-159.13K
24 Q4	-230.25K
24 Q3	-149.78K
24 Q2	-75.53K
24 Q1	-37.83K

EBITDA (USD)

PAYD EBITDA (USD) by quarter
Period	EBITDA (USD)
26 Q2	58.38K
26 Q1	-35.66K
25 Q4	-33.16K
25 Q3	114.77K
25 Q2	-326.4K
25 Q1	-71.05K
24 Q4	-158.44K
24 Q3	-67.33K
24 Q2	5.79K
24 Q1	45.11K

Cash Flows (USD)

PAYD Cash Flows (USD) by quarter
Period	Cash Flows (USD)
26 Q2	216.76K
26 Q1	-132.78K
25 Q4	25.84K
25 Q3	172.84K
25 Q2	223.25K
25 Q1	-477.57K
24 Q4	590.43K
24 Q3	-219.43K
24 Q2	302.2K
24 Q1	-232.08K

EPS (USD)

PAYD EPS (USD) by quarter
Period	EPS (USD)
26 Q2	-0
26 Q1	-0
25 Q4	0.02
25 Q3	0
25 Q2	-0.05
25 Q1	-0.02
24 Q4	-0.02
24 Q3	-0.02
24 Q2	0.1
24 Q1	0.04

Expenses (USD)

PAYD Expenses (USD) by quarter
Period	Expenses (USD)
26 Q2	407.45K
26 Q1	1.11M
25 Q4	-2.45M
25 Q3	385.49K
25 Q2	1.54M
25 Q1	525.12K
24 Q4	1.02M
24 Q3	512.92K
24 Q2	482.51K
24 Q1	988.53K

Cash & Debt (USD)

PAYD Cash & Debt (USD) by quarter
Period	Cash & Debt (USD)
26 Q2	1.08M
26 Q1	951.7K
25 Q4	1.11M
25 Q3	1.15M
25 Q2	1.07M
25 Q1	751.1K
24 Q4	1.28M
24 Q3	1.09M
24 Q2	1.5M
24 Q1	1.27M

Debt ratios

PAYD Debt ratios by quarter
Period	Debt ratios
26 Q2	-9.62
26 Q1	2.83
25 Q4	3.21
25 Q3	2.38
25 Q2	1.54
25 Q1	2.2
24 Q4	6.67
24 Q3	-31.99
24 Q2	-12.9
24 Q1	-9.71

Margins

PAYD Margins by quarter
Period	Margins
26 Q2	20.88%
26 Q1	4.75%
25 Q4	21.24%
25 Q3	23.19%
25 Q2	22.14%
25 Q1	23.3%
24 Q4	16.03%
24 Q3	24.38%
24 Q2	24.06%
24 Q1	8.96%

Return on Capital

PAYD Return on Capital by quarter
Period	Return on Capital
26 Q2	-0.13%
26 Q1	-0.74%
25 Q4	2.63%
25 Q3	0.63%
25 Q2	-7.93%
25 Q1	-3.08%
24 Q4	-3.44%
24 Q3	-2.49%
24 Q2	14.01%
24 Q1	6.31%

Shares Outstanding

PAYD Shares Outstanding by quarter
Period	Shares Outstanding
26 Q2	8.62M
26 Q1	8.55M
25 Q4	8.38M
25 Q3	8.53M
25 Q2	8.3M
25 Q1	8.07M
24 Q4	8.07M
24 Q3	8.06M
24 Q2	8.07M
24 Q1	8.03M

Book Value Per Share (USD)

PAYD Book Value Per Share (USD) by quarter
Period	Book Value Per Share (USD)
26 Q2	0.66
26 Q1	0.66
25 Q4	0.66
25 Q3	0.6
25 Q2	0.6
25 Q1	0.6
24 Q4	0.62
24 Q3	0.67
24 Q2	0.68
24 Q1	0.59

Total Assets (USD)

PAYD Total Assets (USD) by quarter
Period	Total Assets (USD)
26 Q2	8.44M
26 Q1	8.39M
25 Q4	8.28M
25 Q3	8.33M
25 Q2	8.19M
25 Q1	7.85M
24 Q4	8.44M
24 Q3	8.38M
24 Q2	8.44M
24 Q1	7.35M

Employee Count

PAYD Employee Count by quarter
Period	Employee Count
2025	29
2024	26
2023	27
2022	22
2021	23
2020	23
2019	17
2018	2
2017	2
2016	2

PE Ratio

PAYD PE Ratio by quarter
Period	PE Ratio
Sep 26	164.38
Sep 26	164.38
Sep 26	159.7
Aug 26	159.7
Aug 26	160.37
Aug 26	164.38
Sep 25	75.81
Sep 25	74.78
Sep 25	76.06
Sep 25	76.06
Aug 25	75.04
Aug 25	75.81
Aug 25	66.59
Aug 25	68.13
Aug 25	68.38
Jul 25	68.13
Jul 25	69.15
Jul 25	69.15
Jul 25	75.04
Jun 25	77.09
Jun 25	75.3
Jun 25	76.83
Jun 25	76.83
May 25	75.3
May 25	75.3
May 25	75.55
May 25	31.59
May 25	31.8
Apr 25	31.8
Apr 25	32.22
Apr 25	15.64
Apr 25	15.95
Mar 25	15.43
Mar 25	16.67
Mar 25	16.67
Mar 25	15.64
Feb 25	15.18
Feb 25	14.87
Feb 25	14.87
Feb 25	14.87
Jan 25	15.9
Jan 25	15.64
Jan 25	15.69
Jan 25	16.51
Jan 25	16.51
Dec 24	14.61
Dec 24	13.59
Dec 24	13.69
Dec 24	14.77
Nov 24	15.28
Nov 24	14.92
Nov 24	14.92
Nov 24	14.13
Nov 24	12.77
Oct 24	13.69
Oct 24	12.24
Oct 24	13.79
Oct 24	15.05
Sep 24	15.54
Sep 24	14.08
Sep 24	10.68
Sep 24	6.8
Aug 24	6.36
Aug 24	6.36
Aug 24	11.02
Aug 24	10.93
Aug 24	13.39
Jul 24	12.71
Jul 24	13.56
Jul 24	12.88
Jul 24	13.05
Jun 24	12.71
Jun 24	13.9
Jun 24	13.56
May 24	13.48
May 24	13.48
May 24	13.48
May 24	36.29
Apr 24	34.02
Apr 24	36.51
Apr 24	34.02
Apr 24	36.29
Mar 24	26.88
Mar 24	27.23
Mar 24	26.88
Mar 24	28.11
Mar 24	27.76
Feb 24	27.23
Feb 24	27.23
Feb 24	27.76
Feb 24	27.23
Jan 24	27.76
Jan 24	26.35
Jan 24	26.35
Jan 24	27.23
Dec 23	25.47
Dec 23	25.35
Dec 23	31.44
Dec 23	30.42
Dec 23	32.65

Free Cash Flow Yield

PAYD Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	1.33%
Sep 26	1.33%
Sep 26	1.37%
Aug 26	1.37%
Aug 26	1.37%
Aug 26	1.33%
Aug 26	1.37%
Jul 26	1.37%
Jul 26	1.37%
Jul 26	1.33%
Jul 26	1.35%
Jul 26	1.41%
Jun 26	1.47%
Jun 26	1.47%
Jun 26	1.33%
Jun 26	1.35%
May 26	1.41%
May 26	1.41%
May 26	1.48%
May 26	-0.34%
May 26	-0.28%
Apr 26	-0.28%
Apr 26	-0.28%
Apr 26	-0.28%
Apr 26	-0.28%
Mar 26	2.49%
Mar 26	2.51%
Mar 26	2.49%
Mar 26	2.47%
Feb 26	2.49%
Feb 26	2.09%
Feb 26	2.09%
Feb 26	1.99%
Jan 26	2.07%
Jan 26	2.06%
Jan 26	2.06%
Jan 26	2.05%
Jan 26	2.02%
Dec 25	1.81%
Dec 25	1.81%
Dec 25	1.81%
Dec 25	1.81%
Nov 25	1.81%
Nov 25	1.81%
Nov 25	1.89%
Nov 25	0.47%
Oct 25	0.47%
Oct 25	0.47%
Oct 25	0.47%
Oct 25	0.47%
Oct 25	0.49%
Sep 25	0.82%
Sep 25	0.83%
Sep 25	0.82%
Sep 25	0.82%
Aug 25	0.83%
Aug 25	0.82%
Aug 25	0.93%
Aug 25	0.91%
Aug 25	0.91%
Jul 25	0.91%
Jul 25	0.9%
Jul 25	0.9%
Jul 25	0.83%
Jun 25	0.8%
Jun 25	0.82%
Jun 25	0.81%
Jun 25	0.81%
May 25	0.82%
May 25	0.82%
May 25	0.82%
May 25	1.83%
May 25	1.82%
Apr 25	1.82%
Apr 25	1.79%
Apr 25	0.49%
Apr 25	0.48%
Mar 25	0.5%
Mar 25	0.46%
Mar 25	0.46%
Mar 25	0.49%
Feb 25	0.51%
Feb 25	0.52%
Feb 25	0.52%
Feb 25	0.52%
Jan 25	0.48%
Jan 25	0.49%
Jan 25	0.49%
Jan 25	0.47%
Jan 25	0.47%
Dec 24	0.53%
Dec 24	0.57%
Dec 24	0.56%
Dec 24	0.52%
Nov 24	0.5%
Nov 24	0.52%
Nov 24	0.52%
Nov 24	0.96%
Nov 24	1.07%
Oct 24	0.99%

Price to Sales

PAYD Price to Sales by quarter
Period	Price to Sales
Sep 26	0.96
Sep 26	0.96
Sep 26	0.93
Aug 26	0.93
Aug 26	0.94
Aug 26	0.96
Aug 26	0.97
Jul 26	0.97
Jul 26	0.97
Jul 26	1.01
Jul 26	0.99
Jul 26	0.95
Jun 26	0.91
Jun 26	0.91
Jun 26	1
Jun 26	0.99
May 26	0.95
May 26	0.95
May 26	0.9
May 26	0.79
May 26	0.96
Apr 26	0.95
Apr 26	0.96
Apr 26	0.96
Apr 26	0.95
Mar 26	0.99
Mar 26	0.98
Mar 26	0.99
Mar 26	1
Feb 26	0.99
Feb 26	1.18
Feb 26	1.18
Feb 26	1.24
Jan 26	1.19
Jan 26	1.2
Jan 26	1.2
Jan 26	1.2
Jan 26	1.22
Dec 25	1.36
Dec 25	1.36
Dec 25	1.36
Dec 25	1.36
Nov 25	1.36
Nov 25	1.36
Nov 25	1.3
Nov 25	1.28
Oct 25	1.28
Oct 25	1.27
Oct 25	1.27
Oct 25	1.27
Oct 25	1.22
Sep 25	1.27
Sep 25	1.25
Sep 25	1.28
Sep 25	1.28
Aug 25	1.26
Aug 25	1.27
Aug 25	1.12
Aug 25	1.14
Aug 25	1.15
Jul 25	1.14
Jul 25	1.16
Jul 25	1.16
Jul 25	1.26
Jun 25	1.29
Jun 25	1.26
Jun 25	1.29
Jun 25	1.29
May 25	1.26
May 25	1.26
May 25	1.27
May 25	1.3
May 25	1.31
Apr 25	1.31
Apr 25	1.32
Apr 25	1.39
Apr 25	1.41
Mar 25	1.37
Mar 25	1.48
Mar 25	1.48
Mar 25	1.39
Feb 25	1.35
Feb 25	1.32
Feb 25	1.32
Feb 25	1.32
Jan 25	1.41
Jan 25	1.39
Jan 25	1.39
Jan 25	1.46
Jan 25	1.46
Dec 24	1.3
Dec 24	1.2
Dec 24	1.21
Dec 24	1.31
Nov 24	1.35
Nov 24	1.32
Nov 24	1.32
Nov 24	1.35
Nov 24	1.22
Oct 24	1.31

EV/EBITDA

PAYD EV/EBITDA by quarter
Period	EV/EBITDA
Sep 26	193.54
Sep 26	193.54
Sep 26	187.76
Aug 26	187.76
Aug 26	188.58
Aug 26	193.54
Apr 25	788.06
Apr 25	804.19
Mar 25	777.3
Mar 25	841.83
Mar 25	841.83
Mar 25	788.06
Feb 25	763.86
Feb 25	747.73
Feb 25	747.73
Feb 25	747.73
Jan 25	801.5
Jan 25	788.06
Jan 25	790.74
Jan 25	833.76
Jan 25	833.76
Dec 24	734.28
Dec 24	680.51
Dec 24	685.89
Dec 24	742.35
Nov 24	769.23
Nov 24	750.41
Nov 24	750.41
Nov 24	188.97
Nov 24	169.55
Oct 24	182.73
Oct 24	161.92
Oct 24	184.12
Oct 24	202.15
Sep 24	209.09
Sep 24	188.28
Sep 24	139.72
Sep 24	84.22
Aug 24	77.98
Aug 24	77.98
Aug 24	70.55
Aug 24	69.93
Aug 24	87.84
Jul 24	82.9
Jul 24	89.07
Jul 24	84.13
Jul 24	85.37
Jun 24	82.9
Jun 24	91.54
Jun 24	89.07
May 24	88.45
May 24	88.45
May 24	88.45
Aug 23	180.02
Aug 23	180.02
Jul 23	184.2
Jul 23	153.54
Jul 23	193.95
Jul 23	209.28
Jun 23	200.92
Jun 23	203.71
Jun 23	203.71
Jun 23	203.71
Jun 23	189.77
May 23	189.77
May 23	189.77
May 23	25.71
May 23	27.19
Apr 23	26.63
Apr 23	26.63
Apr 23	26.82
Apr 23	28.66
Mar 23	29.03
Mar 23	30.69
Mar 23	30.91
Mar 23	31.37
Mar 23	29.78
Feb 23	30.91
Feb 23	27.74
Feb 23	28.87
Feb 23	25.7
Jan 23	25.02
Jan 23	24.12
Jan 23	21.85
Jan 23	20.49
Dec 22	20.72
Dec 22	18.68
Dec 22	36.8
Dec 22	36.35
Dec 22	36.35
Nov 22	36.58
Nov 22	37.26
Nov 22	46.23
Nov 22	46.8
Oct 22	45.37
Oct 22	52.21
Oct 22	52.21
Oct 22	52.21
Sep 22	51.07
Sep 22	51.07

Price/Operating Cashflow

PAYD Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Sep 26	74.18
Sep 26	74.18
Sep 26	72.07
Aug 26	72.07
Aug 26	72.37
Aug 26	74.18
Aug 26	71.68
Jul 26	71.68
Jul 26	71.68
Jul 26	74.31
Jul 26	72.85
Jul 26	69.94
Jun 26	67.02
Jun 26	67.02
Jun 26	74.01
Jun 26	72.85
May 26	69.94
May 26	69.94
May 26	66.44
Mar 26	40.02
Mar 26	39.69
Mar 26	40.02
Mar 26	40.36
Feb 26	40.02
Feb 26	47.69
Feb 26	47.69
Feb 26	50.03
Jan 26	48.19
Jan 26	48.36
Jan 26	48.36
Jan 26	48.53
Jan 26	49.19
Dec 25	54.86
Dec 25	54.86
Dec 25	54.86
Dec 25	54.86
Nov 25	54.86
Nov 25	55.03
Nov 25	52.7
Nov 25	210.6
Oct 25	210.6
Oct 25	209.21
Oct 25	209.21
Oct 25	209.21
Oct 25	201.54
Sep 25	122.23
Sep 25	120.58
Sep 25	122.64
Sep 25	122.64
Aug 25	120.99
Aug 25	122.23
Aug 25	107.37
Aug 25	109.84
Aug 25	110.26
Jul 25	109.84
Jul 25	111.5
Jul 25	111.5
Jul 25	120.99
Jun 25	124.3
Jun 25	121.41
Jun 25	123.88
Jun 25	123.88
May 25	121.41
May 25	121.41
May 25	121.82
May 25	53.89
May 25	54.25
Apr 25	54.25
Apr 25	54.97
Apr 25	192.81
Apr 25	196.6
Mar 25	190.28
Mar 25	205.45
Mar 25	205.45
Mar 25	192.81
Feb 25	187.12
Feb 25	183.33
Feb 25	183.33
Feb 25	183.33
Jan 25	195.97
Jan 25	192.81
Jan 25	193.44
Jan 25	203.55
Jan 25	203.55
Dec 24	180.16
Dec 24	167.52
Dec 24	168.79
Dec 24	182.06
Nov 24	188.38
Nov 24	183.96
Nov 24	183.96
Nov 24	100.85
Nov 24	91.15
Oct 24	97.74
Oct 24	87.34
Oct 24	98.43
Oct 24	107.44
Sep 24	110.91
Sep 24	100.51
Sep 24	76.25

Price to Book

PAYD Price to Book by quarter
Period	Price to Book
Sep 26	3.72
Sep 26	3.72
Sep 26	3.62
Aug 26	3.62
Aug 26	3.63
Aug 26	3.72
Aug 26	3.73
Jul 26	3.73
Jul 26	3.73
Jul 26	3.86
Jul 26	3.79
Jul 26	3.63
Jun 26	3.48
Jun 26	3.48
Jun 26	3.85
Jun 26	3.79
May 26	3.63
May 26	3.63
May 26	3.45
May 26	2.95
May 26	3.57
Apr 26	3.54
Apr 26	3.57
Apr 26	3.57
Apr 26	3.55
Mar 26	3.98
Mar 26	3.95
Mar 26	3.98
Mar 26	4.01
Feb 26	3.98
Feb 26	4.74
Feb 26	4.74
Feb 26	4.97
Jan 26	4.79
Jan 26	4.81
Jan 26	4.81
Jan 26	4.82
Jan 26	4.89
Dec 25	5.45
Dec 25	5.45
Dec 25	5.45
Dec 25	5.45
Nov 25	5.45
Nov 25	5.47
Nov 25	5.24
Nov 25	5
Oct 25	5
Oct 25	4.97
Oct 25	4.97
Oct 25	4.97
Oct 25	4.79
Sep 25	4.95
Sep 25	4.88
Sep 25	4.96
Sep 25	4.96
Aug 25	4.9
Aug 25	4.95
Aug 25	4.34
Aug 25	4.44
Aug 25	4.46
Jul 25	4.44
Jul 25	4.51
Jul 25	4.51
Jul 25	4.9
Jun 25	5.03
Jun 25	4.91
Jun 25	5.01
Jun 25	5.01
May 25	4.91
May 25	4.91
May 25	4.93
May 25	4.8
May 25	4.83
Apr 25	4.83
Apr 25	4.9
Apr 25	4.57
Apr 25	4.66
Mar 25	4.51
Mar 25	4.87
Mar 25	4.87
Mar 25	4.57
Feb 25	4.44
Feb 25	4.35
Feb 25	4.35
Feb 25	4.35
Jan 25	4.65
Jan 25	4.57
Jan 25	4.59
Jan 25	4.83
Jan 25	4.83
Dec 24	4.27
Dec 24	3.97
Dec 24	4
Dec 24	4.32
Nov 24	4.47
Nov 24	4.36
Nov 24	4.36
Nov 24	4.27
Nov 24	3.86
Oct 24	4.13

No video analysis for this stock yet. Request one from our team.

News: PAYD

seekingalpha.com · 1 Jul 2026

Here's Why Zymeworks Inc. Paid $929M For Theravance Biopharma

Zymeworks Inc. acquires Theravance Biopharma for $929M, pivoting to a hybrid biotech and royalty/cash-flow platform anchored by Yupelri. ZYME gains durable, growing cash flows—$60M annually from Yupelri—with patent protection to 2039, supporting internal R&D and reducing reliance on equity issuance. The acquisition's innovative financing structure ringfences risk, offers immediate accretion, and diversifies revenue beyond oncology, enhancing earnings visibility.

AI Analysis

PAID, Inc.

Video analysis: PAYD

News: PAYD

Here's Why Zymeworks Inc. Paid $929M For Theravance Biopharma

Similar companies